采用磁共振引导立体定向激光消融治疗癫痫病灶的初步临床经验与教训
该研究回顾了2018至2020年间连续16例难治性癫痫患者接受MRgLITT的临床资料,共完成17次手术。术后即刻MRI显示16/17例病灶消融良好,随访超过12个月的11例中7例(63%)达到Engel I级,无神经并发症,提示MRgLITT可作为开放切除术的替代方案。
要点
- MRgLITT在16例难治性癫痫中安全可行,无神经并发症。
- 随访超12个月者Engel I级达63%,与近期文献相当。
- 1例因导管位置欠佳未消融,后成功再手术。
核心结论
- MRgLITT是一种有前景的技术,可安全用于病灶性和非病灶性难治性癫痫,作为开放切除术的替代方案。
- 本系列癫痫手术成功率与近期发表文献相当。
研究设计与样本
- 回顾性连续病例系列,纳入2018至2020年接受MRgLITT的难治性癫痫患者16例,共17次手术。
- 复习病历和影像学资料,利用术后MRI计算消融体积。
主要发现
- 手术指征包括颞叶癫痫7例、疑似低级别胶质瘤4例、影像学皮质发育不良1例、下丘脑错构瘤1例、MR阴性病灶3例。
- 消融使用Visualase系统最大能量的30%至70%,病灶长度7.4至38.1 mm,消融体积0.27至6.78 mm³。
- 术后即刻MRI显示16/17例癫痫病灶消融良好;1例因导管位置欠佳未消融,后成功再手术。
- 平均随访14.9个月(±11.6个月),11例随访超过12个月;7/11例(63%)达到Engel I级,1/11例(9%)为Engel IIIa级,3例(27%)为Engel IV级,其中1例死于癫痫猝死(SUDEP)。
- 随访期间未记录到即刻或迟发性神经并发症。
临床怎么用
- 对于药物难治性癫痫,尤其病灶性和非病灶性病例,MRgLITT可作为开放切除术的微创替代方案。
- 术中需注意导管位置,必要时沿导管轨迹回撤光纤进行序贯消融。
局限性
- 样本量小(16例),随访时间有限(平均14.9个月),部分患者随访不足12个月。
- 为单中心回顾性研究,缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: MR-guided laser interstitial thermal therapy (MRgLITT) is a minimally invasive technique for ablating brain lesions under real-time MRI feedback and control of the ablation process. The Medtronic Visualase system was recently approved for use in Europe and Israel. We report our initial technical experience using the system in the first 16 cases in which the system was used to ablate focal epileptogenic lesions. METHODS: We included all consecutive patients with intractable epilepsy who underwent MRgLITT procedures between 2018 and 2020. We reviewed medical charts and imaging studies of patients. Post-ablation MRIs were used to calculate ablation volumes. RESULTS: Seventeen MRgLITT procedures were performed in 16 patients. One cooling catheter/laser fiber assemblies were placed per patient. Indications for surgery were intractable epilepsy due to TLE (n = 7), suspected low-grade glioma (n = 4), radiological cortical dysplasia (n = 1), hypothalamic hamartoma (n = 1), and MR-negative foci (n = 3). Ablations were made using 30 to 70% of the maximal energy of the Visualase system. We used serial ablations as needed along the tract of the catheter by pulling back the optic fiber; the length of the lesion ranged between 7.4 and 38.1 mm. Ablation volume ranged between 0.27 and 6.78 mm3. Immediate post-ablation MRI demonstrated good ablation of the epileptic lesion in 16/17 cases. In one case with mesial temporal sclerosis, no ablation was performed due to suboptimal position of the catheter. That patient was successfully reoperated at a later date. Mean follow-up was 14.9 months (± 11.6 months). Eleven patients had follow-up longer than 12 months. Good seizure control (Engel I, A) was achieved in 7/11 patients (63%) and 1/11 (9%) had significant improvement in seizure frequency (Angle IIIa). Three patients (27%) did not experience improvement in their seizure frequency (Engel IV, B), and one of these patients died during the follow-up period from sudden unexpected death of epilepsy (SUDEP). No immediate or delayed neurological complications were documented in any of the cases during the follow-up period. CONCLUSIONS: MRgLITT is a promising technique and can be used safely as an alternative to open resection in both lesional and non-lesional intractable epilepsy cases. In our local series, the success rate of epilepsy surgery was comparable to recent publications.
引用
- Shofty B, Bergman L, Berger A, et al. Adopting MR-guided stereotactic laser ablations for epileptic lesions: initial clinical experience and lessons learned. Acta Neurochir (Wien). 2021. PMID: 34269876. doi:10.1007/s00701-021-04903-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。